Interview: German Diagnostics Industry Questions Wisdom Of Reducing Coronavirus Test Reimbursement
COVID-19 testing capacity remains a priority, but reimbursement issues have come back onto agenda for Germany IVD manufacturers
Executive Summary
German reimbursement of COVID-19 confirmatory tests has been reduced by one third, a decision that has frustrated both the testing labs and the diagnostics manufacturers who jointly provided the basis of the system that kept the coronavirus to within manageable proportions nationally.
You may also be interested in...
Coronavirus Antigen Testing Gets Green Light In Germany
Germany is adjusting the national COVID-19 testing strategy, which from mid-October will include the use of antigen tests.
German Industry Warns EU Over MDR: Don’t Waste The Extra Time For Compliance
Germany’s medtech industry fears that the European Commission has been too distracted by the pandemic and must now focus on the operational necessities of ensuring the forthcoming MDR system is fit to use.
A Vital Few Weeks Were Key To Allowing An Effective COVID-19 Control Platform In Germany
Luck had a role in Germany’s coronavirus control success, health minister Jens Spahn has claimed, but the facts show that it is not as simple as that.